Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 BRUIN CLL-322 trial of Jaypirca ...
1don MSN
Eli Lilly's Jaypirca builds case with fourth positive phase 3 trial in blood cancer patients
Eli Lilly and Co. LLY shares were little changed in Monday’s premarket session. The U.S. drug giant shared results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results